Skip to main content
. 2020 Jan 2;8:1. doi: 10.1186/s40560-019-0415-z

Table 3.

Secondary outcomes

Data field DEX group
(n = 54)
Non-DEX group
(n = 50)
P value
Renal replacement therapy in ICU, n (%) 27 (50) 29 (58) 0.41
Ventilator-free days, d, median (IQR) 18 (0, 23) 5 (0, 20) 0.09
28-day mortality, n (%) 12 (22) 21 (42) 0.03
Hospital mortality, n (%) 15 (28) 26 (52) 0.01

DEX dexmedetomidine, ICU intensive care unit, IQR interquartile range

We showed p<0.05 in italic font.